Laser Photonics Subsidiary CMS Laser Wins New Order from Electrical Automation Professionals

Laser Photonics' subsidiary CMS Laser secured a new order from EAP Lasers for a high-speed CO₂ Laser Drilling System. This marks the first of a series of orders expected in the next 12 months, highlighting strategic growth in the pharmaceutical industry. The acquisition of CMS Laser by Laser Photonics has proven strategic, underscoring the subsidiary's contribution to the company's overall growth strategy.

Laser Photonics Corporation (NASDAQ: LASE) has announced that its subsidiary, CMS Laser, has secured a new order from EAP Lasers, a division of Electrical Automation Professionals, for a high-speed CO₂ Laser Drilling System. This order marks the first in a series of expected orders scheduled for delivery over the next 12 months, highlighting the strategic growth potential in the pharmaceutical industry for both companies.

The custom-built system, integrated with CMS Laser's proprietary software controls, will be supplied to EAP Lasers, a Pennsylvania-based company specializing in laser drilling systems for the pharmaceutical industry. The order underscores the robust demand for advanced, reliable laser solutions and paves the way for sustained long-term growth for Laser Photonics.

The acquisition of CMS Laser by Laser Photonics in late 2024 has proven strategic, demonstrating the subsidiary's contribution to the company's growth strategy. CMS Laser's expertise in software controls for laser machines complements Laser Photonics' broader laser technology portfolio, enabling penetration into high-margin pharma and medical device markets.

The high-speed CO₂ Laser Drilling System ordered by EAP Lasers is designed for pharmaceutical applications, including the production of osmotic pump time-release medications. The system features a 140,000 tablets per hour drilling capacity with 200% vision inspection, ensuring zero defects, and anti-counterfeit marking at 70,000 tablets per hour, embedding unique identifiers into drug coatings to combat counterfeiters. The system runs proprietary software (CMS LaserDrill) on Windows® 10, with integrated diagnostics and ESD control for compliance with FDA (CFR-21 Part 11) and GMP standards.

This collaboration highlights CMS Laser's continued growth in strategic industrial markets and its commitment to delivering reliable, cutting-edge laser solutions. The order is part of a broader pipeline of expected orders, providing clear revenue visibility for Laser Photonics over the next 12 months.

References:
[1] https://www.stocktitan.net/news/LASE/laser-photonics-subsidiary-cms-laser-wins-new-order-from-electrical-ayx50wq3l0et.html
[2] https://www.ainvest.com/news/laser-photonics-precision-lasers-drive-pharma-growth-valuation-upside-2507/